[Insulin resistance].

Nobuyuki Ura(Naruto, Tokushima Prefecture hospital), Shinya Taniguchi(Konan University)
PubMed
July 1, 2006
Cited by 0

Related Papers

Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial
|˜The œLancet. Gastroenterology & hepatology|2018|174
Olmesartan Is an Angiotensin II Receptor Blocker with an Inhibitory Effect on Angiotensin-Converting Enzyme
|Hypertension Research|2006|135
A Homologue ofN-Ethylmaleimide-sensitive Factor in the Malaria ParasitePlasmodium falciparum Is Exported and Localized in Vesicular Structures in the Cytoplasm of Infected Erythrocytes in the Brefeldin A-sensitive Pathway
|Journal of Biological Chemistry|2001|72
Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial
|Journal of Gastroenterology|2017|62
Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients
|Journal of Hypertension|2014|48